Welcome to Paid Research Studies




  • Conditions:   Acute Myelogenous Leukemia AML;   Myelodysplastic Syndrome MDS
    Intervention:   Drug: Vidaza and Valproic Acid
    Sponsor:   Patrick Stiff
    Recruiting

  • Condition:   Migraine in Children
    Interventions:   Drug: Valproic Acid (VPA);   Drug: Dihydroergotamine (DHE)
    Sponsor:   Kimberly S Jones
    Recruiting

  • Conditions:   Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Stage I Intraocular Melanoma;   Stage IIA Intraocular Melanoma;   Stage IIB Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma
    Interventions:   Drug: Sunitinib;   Drug: Valproic Acid
    Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Pfizer
    Recruiting

  • Conditions:   Glioblastoma;   Recurrent Adult Brain Neoplasm;   Malignant Glioma;   WHO Grade III Glioma
    Interventions:   Drug: sorafenib tosylate;   Drug: valproic acid;   Drug: sildenafil citrate
    Sponsors:   Virginia Commonwealth University;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Advanced Malignant Neoplasm;   Castleman Disease;   Digestive System Carcinoma;   Erdheim-Chester Disease;   Lip and Oral Cavity Carcinoma;   Lymphangioleiomyomatosis;   Malignant Endocrine Neoplasm;   Malignant Female Reproductive System Neoplasm;   Malignant Male Reproductive System Neoplasm;   Malignant Neoplasm;   Malignant Respiratory Tract Neoplasm;   Malignant Thoracic Neoplasm;   Malignant Urinary System Neoplasm;   Mesothelial Neoplasm;   Metastatic Malignant Neoplasm;   Metastatic Urothelial Carcinoma;   Neurofibromatosis Type 2;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Breast Carcinoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Digestive System Carcinoma;   Recurrent Female Reproductive System Carcinoma;   Recurrent Male Reproductive System Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Pharyngeal Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Refractory Malignant Neoplasm;   Soft Tissue Neoplasm;   Stage III Breast Cancer AJCC v7;   Stage III Pharyngeal Cancer;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7;   Stage IV Breast Cancer AJCC v6 and v7;   Stage IV Pharyngeal Cancer;   Stage IVA Pharyngeal Cancer;   Stage IVB Pharyngeal Cancer;   Stage IVC Pharyngeal Cancer;   Thyroid Gland Neoplasm
    Interventions:   Biological: Bevacizumab;   Biological: Cetuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temsirolimus;   Drug: Valproic Acid
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Alcohol Withdrawal Syndrome
    Interventions:   Drug: Gabapentin;   Drug: Benzodiazepines;   Drug: Divalproex Sodium
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Hematological Malignancy;   Acute Leukemia in Remission;   Acute Lymphoblastic Leukemia in Remission;   Myelodysplastic Syndromes;   Non-Hodgkin Lymphoma;   Hodgkin Lymphoma
    Interventions:   Biological: Cord blood stem cells;   Drug: Valproic Acid;   Drug: Fludarabine;   Drug: cytoxan;   Drug: Thiotepa;   Biological: TBI
    Sponsor:   Alla Keyzner
    Recruiting

  • Condition:   Bipolar Disorder
    Interventions:   Drug: Fluoxetine;   Drug: Citalopram
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Conditions:   Acute Kidney Injury;   Renal Insufficiency;   Renal Failure;   Pharmacokinetics
    Interventions:   Drug: Levetiracetam;   Drug: Lacosamide;   Drug: Phenytoin;   Drug: Phenobarbital;   Drug: Ketamine;   Drug: Valproic Acid
    Sponsors:   University of Maryland;   Center for Translational Medicine (CTM), University of Maryland School of Pharmacy
    Recruiting

  • Conditions:   Epilepsy;   Obese
    Intervention:   Other: Anti-epileptics
    Sponsors:   Christoph P Hornik, MD MPH;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The EMMES Corporation
    Recruiting